| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President & CEO
2 companies
Brian Concannon last filed a Form 4 in June 2025, as President & CEO at HAE. The filings on record cover 2 companies. From January 2015 to June 2025, the filings on record show 0 open-market purchases and 17 sales. Brian Concannon's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Brian Concannon a strong insider score of 70/100, based on 3 past trades. Over a 12-month horizon, all 3 of those trades were profitable, with an average 12-month return of +36.1%.
At the last filing, the largest reported position was 147,040 shares of HAE. The HAE filings lean toward selling, a net 69,161 shares.
Shares as reported in the last Form 4 for each company; the most recent is from June 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2015 | HAE Haemonetics Corp | President & CEO | Sale+OE | 6,569 | $42.51 | $279,221.26 | -4.3% | |
| Jun 1, 2015 | HAE Haemonetics Corp | President & CEO | Sale+OE | 4,765 | $41.39 | $197,214.30 | -3.1% | |
| May 1, 2015 | HAE Haemonetics Corp | President & CEO | Sale+OE | 4,765 | $40.74 | $194,138.97 | -3.1% | |
| Apr 1, 2015 | HAE Haemonetics Corp | President & CEO | Sale+OE | 4,765 | $44.51 | $212,076.33 | -3.1% | |
| Mar 2, 2015 | HAE Haemonetics Corp | President & CEO | Sale+OE | 4,765 | $44.41 | $211,617.46 | -3.1% | |
| Feb 2, 2015 | HAE Haemonetics Corp | President & CEO | Sale+OE | 4,765 | $39.15 | $186,530.21 | -3.1% | |
| Jan 2, 2015 | HAE Haemonetics Corp | President & CEO | Sale+OE | 4,765 | $37.20 | $177,251.81 | -3.1% |